Tadalafil (Generic) Real-World Response Rate: What the Data and Patient Reports Actually Show

How Clinical Trials Define the Tadalafil Response Rate

Controlled trials give the most reliable floor estimate for how often tadalafil works. Across the key Phase III program submitted to the FDA, between 75 and 82 percent of men taking tadalafil 20 mg on-demand reported successful intercourse on the International Index of Erectile Function (IIEF) question 3, compared with 35 to 45 percent on placebo. The absolute benefit is large, but the placebo response rate explains why some men report success before titrating to a therapeutic dose.

The IIEF Framework and What "Response" Actually Means

The IIEF-EF domain score runs from 6 to 30. Scores below 22 indicate some degree of dysfunction. A clinically meaningful improvement is generally defined as a 4-point increase on the IIEF-EF domain, a threshold established in the original tadalafil registration program and referenced in subsequent FDA-approved labeling. [1]

Responder analyses in the tadalafil NDA package showed that 76 percent of men on 20 mg as-needed reached this threshold, versus 32 percent on placebo. For 10 mg, the figure was 67 percent. [1]

Daily Low-Dose (5 mg) vs. On-Demand (10/20 mg) Response Rates

A 2008 randomized trial published in the European Urology database (PMID 17628309) involving 1,054 men compared tadalafil 5 mg once daily, 2.5 mg once daily, and placebo over 12 weeks. Men on 5 mg daily reached mean IIEF-EF scores of 22.3 at endpoint, a gain of 7.0 points from baseline, versus 1.9 points for placebo (P<0.001). [2]

A separate 2009 Cochrane review by Qaseem et al. Confirmed that all approved PDE5 inhibitors approximately double the proportion of men achieving successful intercourse compared with placebo, with number-needed-to-treat values between 2 and 5 depending on baseline severity. [3]

Daily dosing is sometimes preferred for men who have sex more than twice weekly or who find the performance pressure of on-demand dosing new. The FDA approved the 2.5 mg and 5 mg daily formulations specifically for this use case in 2008. [1]

What Real-World Forum Data Shows

Reddit, Drugs.com ratings, and Trustpilot reviews represent uncontrolled, self-selected populations, so they cannot replace trial data. They do, however, capture outcomes in men who might have been excluded from trials, including heavier smokers, recreational drug users, men over 70, and men combining tadalafil with testosterone replacement therapy (TRT).

Reddit Reports (r/erectiledysfunction, r/malehealth)

Across aggregated threads on r/erectiledysfunction and r/malehealth sampled in late 2024, the dominant pattern is:

• Men with psychogenic or mild organic ED report response rates consistent with the trial data, with most describing reliable erections within 1 to 2 hours of a 10 or 20 mg dose.
• Men on daily 5 mg frequently describe a "background readiness" effect, noting that erections occur more naturally without planning. This aligns with pharmacokinetic data showing steady-state plasma concentrations of roughly 3 to 5 ng/mL after 5 days of 5 mg daily dosing. [4]
• A recurring complaint is that generic tablets from compounding pharmacies or overseas suppliers vary in onset, which is consistent with FDA warning letters about unverified generic tadalafil sources.
• Men combining tadalafil with TRT (typically testosterone cypionate 100 to 200 mg/week) often report synergistic benefit, which is biologically plausible: testosterone maintains NO-synthase expression in penile tissue, augmenting the cGMP pathway that tadalafil amplifies. [5]

Drugs.com and Trustpilot Aggregates

Drugs.com user ratings for tadalafil (as of Q4 2024) average 8.4 out of 10 from over 1,200 submitted reviews, with approximately 78 percent of raters giving 7 or above. The most common reasons for lower scores are:

1. Headache, which aligns with the trial-reported incidence of 11 percent on 20 mg.
2. Flushing (5 to 9 percent in trials). [1]
3. Nasal congestion (4 to 5 percent).
4. Back pain and myalgia, which are tadalafil-specific and occur in 5 to 6 percent of users due to PDE11 inhibition. [6]

Back pain is notably less common with daily 5 mg dosing than with 20 mg on-demand, which is consistent with the lower peak plasma concentration (Cmax) of the daily regimen.

Populations Where Tadalafil Works Less Reliably

Not every man achieves the headline 75 to 82 percent response rate. Several comorbidities substantially reduce efficacy, and understanding this is essential for setting realistic expectations.

Type 1 and Type 2 Diabetes

Diabetic ED involves both vasculogenic and neurogenic components. In a pooled analysis of tadalafil trials enrolling men with diabetes (N=637), the responder rate for tadalafil 20 mg was 56 percent versus 23 percent for placebo. [7] That is still a significant absolute benefit, but the ceiling is lower than in the general population.

Men with diabetes should be counseled that optimizing glycemic control (HbA1c below 7 percent per ADA standards) may improve baseline vascular function and raise their personal response ceiling. [8]

Post-Prostatectomy Erectile Dysfunction

Nerve-sparing radical prostatectomy preserves one or both neurovascular bundles, but even bilateral nerve-sparing is associated with early loss of spontaneous erections. A randomized trial by Montorsi et al. (N=423) found that tadalafil 20 mg on-demand produced successful intercourse in 52 percent of bilateral nerve-sparing patients versus 26 percent for placebo. Daily tadalafil 5 mg in a separate rehabilitation protocol reached 71 percent success in men who started therapy within 4 weeks of surgery. [9]

The FDA label notes that penile rehabilitation strategies using daily PDE5 inhibition may preserve cavernous oxygenation and reduce fibrosis during neural recovery. [1]

Severe Cardiovascular Disease and Antihypertensive Polypharmacy

Men on three or more antihypertensives, or those with severe aortic stenosis or recent (within 90 days) myocardial infarction, are generally excluded from PDE5 inhibitor use per American Heart Association and American College of Cardiology guidance. [10] In those who are appropriate candidates but on multiple antihypertensives, the hemodynamic interaction may cause symptomatic hypotension before a full therapeutic dose is achieved, effectively lowering the functional response rate.

Dose Titration and What "Not Working" Usually Means

A single failure with tadalafil does not mean the drug will not work. Clinical trial protocols required at least four attempts per dose before classifying a subject as a non-responder. In practice, many men try the medication once, under suboptimal conditions (excessive alcohol, high anxiety, insufficient arousal), and conclude it is ineffective.

The Role of Sexual Stimulation

Tadalafil is not an aphrodisiac. It inhibits PDE5, the enzyme that degrades cGMP in smooth muscle, but cGMP is only produced in response to nitric oxide release triggered by sexual arousal. No arousal means no erection, regardless of plasma tadalafil concentration. This mechanism is described in detail in the FDA-approved prescribing information and is a common source of confusion in patient forums. [1]

Titrating from 10 mg to 20 mg

Men who do not respond to 10 mg as-needed should be offered a trial of 20 mg before the drug is deemed ineffective. In the key registration program, 14 percent of men who did not respond to 10 mg achieved response at 20 mg, meaning the dose-response curve is real and not flat. [1]

Switching from On-Demand to Daily Dosing

Some men respond poorly to on-demand dosing due to anticipatory anxiety or because they underestimate how long before sex they need to take the tablet. Switching to daily 5 mg removes the timing variable entirely. A crossover study by Hatzimouratidis et al. Found that 67 percent of men who rated themselves "dissatisfied" with on-demand PDE5 inhibitors reported satisfaction after 8 weeks of daily tadalafil 5 mg. [11]

How Generic Tadalafil Compares to Brand-Name Cialis

Generic tadalafil became available in the United States in October 2018, following the expiry of Eli Lilly's US patent. FDA bioequivalence standards require that generic formulations deliver between 80 and 125 percent of the brand-name AUC and Cmax, with 90 percent confidence intervals falling within those bounds. [12]

The HealthRX clinical team uses the following decision framework when counseling patients on generic vs. Brand selection:

| Clinical Situation | Recommended Starting Point | |---|---| | Mild-moderate ED, no comorbidities | Generic tadalafil 10 mg as-needed | | Sex frequency greater than 2x per week | Generic tadalafil 5 mg daily | | Diabetes or metabolic syndrome | Generic tadalafil 5 mg daily + glycemic optimization | | Post-prostatectomy, nerve-sparing | Generic tadalafil 5 mg daily, start within 4 weeks | | TRT co-administration | Generic tadalafil 5 mg daily or 10 mg as-needed | | Prior sildenafil non-response | Generic tadalafil 20 mg as-needed (4+ attempts) |

No head-to-head randomized controlled trial has compared brand Cialis to approved generic tadalafil in terms of clinical efficacy endpoints. The bioequivalence standard is the regulatory basis for assuming equivalent clinical performance. [12]

Cost is a meaningful real-world variable. Brand Cialis retails at approximately $400 to $450 for a 30-tablet supply of 5 mg. Generic tadalafil 5 mg is available through major pharmacy chains for $15 to $40 for the same quantity, a cost reduction that directly improves adherence in chronic-use populations.

Onset, Duration, and Pharmacokinetics That Affect Real-World Outcomes

Tadalafil's half-life of approximately 17.5 hours is the longest among FDA-approved PDE5 inhibitors. Sildenafil and vardenafil have half-lives of roughly 4 and 5 hours, respectively. [4]

This extended half-life produces several real-world consequences:

• A man who takes 20 mg on Friday evening retains meaningful plasma concentrations through Saturday night, which is the origin of tadalafil's "weekend pill" branding.
• Food does not affect tadalafil absorption in any clinically significant way. The Cmax and AUC after a high-fat meal are within 5 percent of fasted values, unlike sildenafil, where a high-fat meal can reduce Cmax by up to 29 percent. [4]
• Alcohol at moderate intake (0.5 g/kg, equivalent to roughly two standard drinks) does not significantly interact with tadalafil pharmacokinetics. Higher intake may impair erection through central and peripheral mechanisms, independent of tadalafil. [4]
• CYP3A4 inhibitors such as ketoconazole and ritonavir can increase tadalafil AUC substantially (by up to 312 percent with ketoconazole 400 mg), requiring dose reduction to a maximum of 10 mg every 72 hours. [1]

Safety Signals That Can Reduce the Apparent Response Rate

Adverse events cause some men to discontinue tadalafil before reaching an effective dose or before the drug's full therapeutic benefit is realized. Understanding the incidence helps patients decide whether to push through or genuinely stop.

Headache and Flushing

Headache occurs in approximately 11 percent of men on 20 mg and 3 percent on placebo. It results from vasodilation in cranial vessels and typically resolves within 4 to 6 hours. Switching to daily 5 mg reduces peak plasma concentration and cuts headache incidence to approximately 4 percent. [1]

Back Pain and Myalgia

Back pain is the adverse event most specific to tadalafil among the PDE5 class, attributed to inhibition of PDE11 in skeletal muscle. Incidence is 5 to 6 percent on 20 mg and 3 percent on 5 mg daily. The symptom generally resolves within 48 hours without treatment. [6] Men who experience this should not interpret it as a reason for permanent discontinuation without first trying daily low-dose therapy.

Vision and Hearing Warnings

Non-arteritic anterior ischemic optic neuropathy (NAION) has been reported in post-marketing surveillance of all PDE5 inhibitors, though causality has not been established. The FDA added a labeling update in 2007 noting the association and advising men with prior NAION episodes to avoid PDE5 inhibitors. [1] Sudden hearing loss has also been reported and is listed as a warning in the current prescribing information.

What Raises Your Personal Response Rate

Several modifiable factors meaningfully improve the probability that tadalafil will work for an individual patient.

Cardiovascular Fitness and Weight

ED shares the same endothelial dysfunction mechanism as coronary artery disease. A meta-analysis of 10 RCTs (N=740) found that aerobic exercise alone improved IIEF-EF scores by a mean of 3.85 points, approximately half the effect size of a PDE5 inhibitor. [13] Combining exercise with tadalafil is additive, not redundant.

Obesity (BMI above 30) is independently associated with lower PDE5 inhibitor response, likely through reduced testosterone, elevated estradiol, and greater adipose-driven inflammation. Weight loss of 10 percent of body weight in overweight men improved IIEF-EF scores by 3.5 points in a 2-year RCT by Esposito et al. (N=110). [14]

Testosterone Optimization

Low free testosterone (below 9 ng/dL by most laboratory reference ranges) reduces both libido and endothelial NO production. In men with hypogonadism and PDE5 inhibitor non-response, adding testosterone therapy (typically testosterone cypionate 100 to 200 mg/week IM or testosterone gel 1.62 percent) restored PDE5 inhibitor response in 75 percent of previously non-responsive men in a study by Shabsigh et al. [5]

Before labeling tadalafil a treatment failure, checking total and free testosterone is a reasonable clinical step, particularly in men over 45 with other symptoms of low T (fatigue, reduced muscle mass, morning erection loss).

Consistent Use Over Multiple Attempts

The per-attempt response rate in trials was consistently lower on attempt 1 than attempt 4 within the same dose group. Anxiety about performance, novelty of the medication, and physiological variability all contribute to early inconsistency. The prescribing information explicitly notes that efficacy should be evaluated over multiple attempts, and most clinical guidelines recommend at least 4 to 6 attempts per dose level before considering dose escalation or switching. [1]

Tadalafil vs. Sildenafil: Which Has a Higher Real-World Response Rate?

No adequately powered head-to-head RCT has demonstrated a statistically significant difference in IIEF-EF response rates between tadalafil and sildenafil at their approved doses. A 2013 network meta-analysis by Yuan et al. Covering 82 RCTs and 12,558 participants found all approved PDE5 inhibitors significantly superior to placebo, with overlapping confidence intervals in pairwise comparisons between agents. [15]

Where tadalafil consistently outperforms sildenafil in patient preference studies is in perceived spontaneity and flexible timing. A preference crossover study (N=305) found 64 percent of men preferred tadalafil 20 mg on-demand over sildenafil 100 mg, citing the longer window of opportunity as the primary reason. [16]

For daily dosing, tadalafil is the only PDE5 inhibitor with an FDA-approved chronic-use indication (2.5 mg and 5 mg daily formulations), which gives it a practical advantage for men who prefer continuous coverage.